Analyzing energetics and dynamics of hepatitis C virus polymerase interactions with marine bacterial compounds: a computational study
- PMID: 38856834
- DOI: 10.1007/s11030-024-10904-x
Analyzing energetics and dynamics of hepatitis C virus polymerase interactions with marine bacterial compounds: a computational study
Abstract
Hepatitis C Virus (HCV) is a significant health concern affecting a large portion of the global population and is a major cause of acute liver diseases, including cirrhosis. The variability in the HCV genome mainly results from the rapid replication facilitated by the NS5B polymerase, making it a prime target for anti-HCV drug development. This study explores potential compounds from marine bacteria that could inhibit the HCV NS5B polymerase by virtual screening, analyzing the energetics, and dynamic behavior of target-compound complexes. Virtual screening with the Lipinski filter was employed to select compounds from the marine bacteria database that demonstrated strong binding affinity to NS5B. The top four (CMNPD27216, CMNPD21066, CMNPD21065, and CMNPD27283) compounds, ranked by their re-docking scores, underwent additional evaluation. Molecular dynamics simulations for 200 ns were conducted to assess the dynamic stability of these complexes in a solvent environment. Furthermore, methods such as MM-GBSA, PCA, and free energy landscape analysis were used to analyze the system's energetics and identify stable conformations by locating transition states. The findings suggest that these compounds exhibit promising binding capabilities to HCV polymerase and could be considered for future experimental validation.
Keywords: Hepatitis C virus; MD simulation; Marine bacterial compounds; PCA-based free energy landscape.
© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Similar articles
-
Regulation of NS5B Polymerase Activity of Hepatitis C Virus by Target Specific Phytotherapeutics: An In-Silico Molecular Dynamics Approach.Cell Biochem Biophys. 2024 Sep;82(3):2473-2492. doi: 10.1007/s12013-024-01359-w. Epub 2024 Jul 23. Cell Biochem Biophys. 2024. PMID: 39042185
-
Screening of hepatitis C NS5B polymerase inhibitors containing benzothiadiazine core: a steered molecular dynamics.J Biomol Struct Dyn. 2017 Jun;35(8):1743-1757. doi: 10.1080/07391102.2016.1193444. Epub 2016 Jun 27. J Biomol Struct Dyn. 2017. PMID: 27236925
-
Probing the "fingers" domain binding pocket of Hepatitis C virus NS5B RdRp and D559G resistance mutation via molecular docking, molecular dynamics simulation and binding free energy calculations.J Biomol Struct Dyn. 2019 Jun;37(9):2440-2456. doi: 10.1080/07391102.2018.1491419. Epub 2018 Nov 13. J Biomol Struct Dyn. 2019. PMID: 30047829
-
Recent advances in discovery and development of promising therapeutics against hepatitis C virus NS5B RNA-dependent RNA polymerase.Mini Rev Med Chem. 2005 Dec;5(12):1103-12. doi: 10.2174/138955705774933310. Mini Rev Med Chem. 2005. PMID: 16375756 Review.
-
Inhibitors of the HCV NS5B polymerase: new hope for the treatment of hepatitis C infections.Curr Opin Investig Drugs. 2004 Aug;5(8):838-50. Curr Opin Investig Drugs. 2004. PMID: 15600240 Review.
Cited by
-
Stereo-selectivity of enantiomeric inhibitors to ubiquitin-specific protease 7 (USP7) dissected by molecular docking, molecular dynamics simulations, and binding free energy calculations.Mol Divers. 2025 Apr;29(2):1725-1735. doi: 10.1007/s11030-024-10948-z. Epub 2024 Sep 19. Mol Divers. 2025. PMID: 39298085
-
Antifungal potential of marine bacterial compounds in inhibiting Candida albicans Yck2 to overcome echinocandin resistance: a molecular dynamics study.Front Pharmacol. 2024 Oct 17;15:1459964. doi: 10.3389/fphar.2024.1459964. eCollection 2024. Front Pharmacol. 2024. PMID: 39484169 Free PMC article.
References
-
- Basyte-Bacevice V, Kupcinskas L (2024) Viral hepatitis C: from unravelling the nature of disease to cure and global elimination. Dig Dis. https://doi.org/10.1159/000539210 - DOI - PubMed
-
- WHO (2024) Hepatitis C. Weblink: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c . Accessed on: 2024–10–04
-
- Mehta P, Reddivari AKR (2024) Hepatitis. StatPearls Publishing, Treasure Island
-
- Reich S, Kovermann M, Lilie H et al (2014) Initiation of RNA synthesis by the hepatitis C virus RNA-dependent RNA Polymerase Is affected by the structure of the RNA template. Biochemistry 53:7002–7012. https://doi.org/10.1021/bi5006656 - DOI - PubMed
-
- Beaulieu PL (2007) Non-nucleoside inhibitors of the HCV NS5B polymerase: progress in the discovery and development of novel agents for the treatment of HCV infections. Curr Opin Investig Drugs 8:614–634 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous